November 6, 2010

Saturday, November 06, 2010

The November 2010 issue of Neurosurgical Focus illustrates concern for young players in Canadian junior ice hockey as researchers have uncovered alarming data and trends regarding head injuries and concussions.
"The aftermath of a concussion can impact memory, judgment, social conduct, reflexes, speech, balance and coordination. Epidemiological studies have suggested an association between sport concussions and both immediate and later-life cognitive impairment. As such, this is a public health issue that needs to be taken more seriously by players, parents, coaches, and medical professionals," said Dr. Echlin.
Although, the issue of sports-related head injuries has been a growing concern for some time, this new study is the first to document the significance of this concern among junior hockey players.

Specifically, the Hockey Concussion Education Project (HCEP), a cohort study conducted between 2009 and 2010, researched 67 male ice-hockey players between the ages of 16 and 21 among two fourth-tier teams.

Before the hockey season began, the players were assessed with the Sideline Concussion Assessment Test (SCAT2) and the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT). Following these tests, players were monitored by one independent physician and one to three independent, non-physician observers, at each regular season game.

The disturbing results…

  • 17 players experienced a total of 21 concussions in only 52 games.

  • 5 of those 17 players suffered a second or recurrent concussion during the hockey season.

  • 15 of the same 17 players admitted to having at least one concussion in the past, while 2 admitted to hiding the fact to continue playing.

  • The positions most affected by concussion are: forward position (71%) and defense (29%).

  • No concussions were incurred by goalies.

  • The rate of concussion increases as the game progresses: first period (14%); second period (29%); and third period (57%).

  • 24% of the concussions occurred in players directly involved in a fight.

  • The mean clinical return-to-play duration in 15 players was 12.8 days.
These statistics suggest that more education is needed to convince players, coaches and parents alike that concussion really is a serious problem that should not be ignored. Testing and monitoring after a concussion occurs is extremely important, however more often than not, the extra attention required is more of a burden to most.

In addition, educating players on the dangers should reduce the number of unreported cases and the concealment of concussions to avoid sitting on the bench. Players need to be aware that concussions are quite common in sport and the tough guy act could have devastating results to both physical and mental abilities that could last decades.

Junior Ice Hockey Study Uncovers Alarming Concussion Rates

© www.mentalhealthblog.com

October 11, 2010

Monday, October 11, 2010
According to a study published in the Journal of Epidemiology and Community Health, light drinking during pregnancy will not harm your child's behavioural or intellectual development.

A past study found similar findings among 3 year olds, but researchers wanted to study older children in case any symptoms had been delayed in the previous research.
“They used data from the Millennium Cohort Study -- a large study tracking the long term health of children born in the UK -- drawing on a representative sample of 11,513 children born between September 2000 and January 2002.”
As in many studies, researchers relied on the mothers self-reports. When children reached 9 months of age, the mothers were questioned about their drinking habits and other social and economic factors surrounding their lives.

Their alcohol consumption was divided into categories set out by the government's National Alcohol Strategy. “The mothers were classified as teetotal; those who drank but not in pregnancy; light (1 or 2 units a week or at any one time); moderate (3 to 6 units a week or 3 to 5 at any one time); and binge/heavy (7 or more units a week or 6 at one sitting).”

Although the study relied on the mothers’ self-reports of their children’s behavior at the age of 3, a formal assessment on behavioral and intellectual development of these children was completed when they reached 5 years of age.

Results showed that just below 6% of the mothers abstained from drinking and 60% abstained from drinking for the duration of the pregnancy alone. Of the mothers that drank during pregnancy, 26% admitted to light drinking, 5.5% were considered moderate drinkers and 2.5% were classified as heavy or binge drinkers.

Findings among all groups revealed that boys were more likely to have developmental problems, behavioral issues, hyperactivity and peer issues. Girls, on the other hand, were more likely to develop emotional problems. Testing also indicated that girls scored higher in cognitive abilities than boys.

As expected, the children of heavy drinking mothers were more likely to have behavioral and emotional issues as well as problems with hyperactivity. However, the findings did not suggest any behavioral or intellectual deficiencies among children whose mothers were considered light drinkers during pregnancy.
“Children born to light drinkers were 30% less likely to have behavioural problems than children whose mothers did not drink during pregnancy. After taking account of a wide range of influential factors, these children achieved higher cognitive scores than those whose mums had abstained from alcohol while pregnant.”
In today's world, attitudes have hardened and the widespread opinion is to avoid any risks and abstain from drinking alcohol, but this study certainly questions these beliefs. Although the findings may turn our views upside-down, it would be helpful to know if these mothers were light drinkers for the entire duration of pregnancy and/or during breastfeeding before alcohol-dependent mothers are given the green light.

Light Drinking During Pregnancy: Harmful to Child's Behavioral or Intellectual Development?

© www.mentalhealthblog.com
Monday, October 11, 2010
The following is an article that mentions Mental Health Blog and outlines my opinion on technology and how it relates to the mental health field.

For those interested in reading the article, please click the following link:

Medical Animation, Technology a Growing Industry

© www.mentalhealthblog.com

September 25, 2010

Saturday, September 25, 2010
Concordia University has published new research in the popular journal, Brain and Cognition, demonstrating that high levels of estrogen, such as those found during the female ovulation period, has an affect on attention and learning.
"Although estrogen is known to play a significant role in learning and memory, there has been no clear consensus on its effect," says senior author Wayne Brake, an associate professor at Concordia's Center for Studies in Behavioural Neurobiology. "Our findings, using a well-established model of learning called latent inhibition, shows conclusively that high estrogen levels inhibit the cognitive ability in female rodents."
Findings in this study resulted from experiments on the latent inhibition of rats. Latent inhibition is a term derived from Classical conditioning. It occurs when a subject takes longer to give meaning to a stimulus that had no previous significance than it would when associated with a new stimulus. It is a natural tendency to disregard or inhibit forming a memory by preventing associative learning of a stimulus with no associated consequence. It is an unconscious response and presumed to prevent sensory overload. “Latent inhibition is observed in many species, and is believed to be an integral part of learning, enabling an organism to interact successfully in an environment.”

The research team discovered that estrogen has a direct effect on the brain. In their experiment, rats were repeatedly exposed to a specific tone that had no consequence linked to it. After some exposure rats began ignoring the tone because they were used to it. The researchers then linked the tone with a different stimulus. Results showed that rats with higher levels of estrogen took much longer to form the association than rats with low levels of estrogen.
"We only observed this effect in adult female rats," says Brake. "This and our other findings indicate that estrogen directly effects the brain, perhaps by interfering with brain signaling molecules. Our study helps clear up the controversy about the effects of estrogen, the next step is to look at how this occurs."
Can't Focus? Maybe It's the Wrong Time of Month, Finds Estrogen Study on Attention and Learning
Latent inhibition

© www.mentalhealthblog.com

September 11, 2010

Saturday, September 11, 2010

It estimated that as many as 70,000 people in New York could be suffering from PTSD because of the attacks on the World Trade Centre seven years ago today. Health officials have determined that more than 400,000 people were exposed to the tragedy on September 11, 2001. Recent data suggests that, of those who experienced the atrocity, 35,000 to 70,000 may have developed PTSD and 3,800 to 12,600 may have developed asthma. There are 71,437 people on the health registry who agreed to be monitored for up to 20 years since the disaster. "Half of those surveyed said they were in the dust cloud left by the collapsing towers, 70 per cent witnessed a traumatic sight – such as a plane hitting a tower or falling bodies – and 13 per cent were injured that day". Of the endless list of rescue and recovery workers, commuters, area workers, Lower Manhattan residents, and passersby, PTSD was highest among those who had sustained injuries (35%), followed by those with low-income (31%), and Hispanic (30%) respondents. Read More

© www.mentalhealthblog.com

August 22, 2010

Sunday, August 22, 2010

Ketamine is a fast-acting liquid anesthetic used mainly by veterinarians; it's also used in human medicine, even in children, because it doesn't depress breathing.

It's also an illegal club drug, known as "special K" or "vitamin K."

The street version is usually sold in a powder form that can be snorted or mixed into drinks, or dissolved into a liquid and injected.

It acts like LSD, causing vivid hallucinations in users and a sensation of floating outside their bodies.
Researchers at Yale University have discovered that a single dose of ketamine helps the brain to form new synaptic connections between neurons and can begin to relieve depressive symptoms in a little as 40 minutes.

In contrast, Prozac and other types of antidepressants can take anywhere from two weeks to a full month before they start to demonstrate any real results, in which benefits can only be seen in about a third of patients. This new antidepressant is now being tested in Canada with promising results.

Dr. James Kennedy, director of the neuroscience research department at the Centre for Addiction and Mental Health in Toronto states that ketamine might alleviate what has been known as a “major clinical problem”. The 2 - 4 weeks that patients await relief is a critical time where devastating outcomes, such as suicide, can occur because they begin to feel more energetic but depressive symptoms remain. Not only is there hope for those with difficult to treat depression, ketamine could actually save lives.
Earlier studies involving patients with "treatment-resistant" depression have found that those given a single dose of ketamine experience rapid and significant improvement in symptoms.

In a small study published earlier this month on patients with bipolar depression, 71 per cent of participants responded to ketamine versus six per cent who responded to placebo.
In addition to being fast-acting, studies show that relief can last for 7 – 10 days, according to professor of psychiatry and neurobiology at Yale, Ronald Duman, who calls ketamine a “magic drug”.

Duman also believes that this so-called magic drug may be able to reverse the effects of stress on the brain by repairing damaged connections between neurons caused by chronic stress.

Although ketamine may not be the ideal long-term solution for treating depression, it could certainly lead to the development of similar compounds that may produce the same effect, but can be more easily administered with less potential for abuse.

"Imagine someone who is in the ER (emergency department) and is highly suicidal. It would be a way to decrease the suicidal risk" says Dr. Pierre Blier, director of mood disorders research at the Institute of Mental Health Research and Canada Research Chair in Psychopharmacology at the Royal Ottawa Mental Health Centre, who has started using ketamine on some of his patients.

Sources:
'Magic drug' gives hope to bipolar patients - Ketamine is mainly used as an anesthetic by vets but shows promise in treating depression

© www.mentalhealthblog.com

August 8, 2010

Sunday, August 08, 2010
Researchers in Toronto, Canada have developed an experimental brain surgery that may delay the progression of Alzheimer’s disease. Six subjects with Alzheimer’s disease and an average age of 61 experienced this surgery called deep brain stimulation. The subjects continued to take their Alzheimer’s medication throughout the study.

Scientists implanted “electrodes in the brain's hippocampus, which plays a role in long-term memory. The electrical conductor acts as a pacemaker-like device in the head just beneath the skin. It is connected to a battery pack in the chest.”

Consequently, the mini-mental state exam, a cognitive test, revealed that half of the participants experienced a slow-down in the degenerative effects Alzheimer’s disease has on the brain, while the other half continued to decline in a manner typical of the disease’s progression.

While this new research has produced some promising results, deep brain stimulation is not a novel idea since it has been around for decades. For instance, Dr. Andres Lozano, a neurosurgeon at Toronto's University Health Network, experimented with its effects on Parkinson’s disease without success, unfortunately.

Although not all subjects experienced positive outcomes with this surgery, 64 year old, former city counselor from Brampton, Ontario, Robert Linton, recalled vivid memories of a day he spent fishing.
"I'm with my son," Linton recalled to reporters at Toronto Western Hospital. "I could see that muskie coming right at me as I was sitting in the chair, in Technicolor". "That's the power of touching a spot in your brain. I'm sold on it."
Currently, Lozano and his research team are recruiting roughly 50 people willing to install the stimulator. The plan is to activate half of the stimulators immediately and the other half only six months later all the while participants’ knowledge of its activation will remain unknown in order to truly test the benefits of the device.

Although, the true value of this device is not yet known, the actual retail cost if this treatment became available, would be between $15,000 and $20,000 per patient with a battery life of up to five years.

At the moment, I’m unsure whether I approve of this type of treatment. For one, results are insufficient therefore there is no real proof that the surgery will benefit enough people. Secondly, I am reminded of electroconvulsive therapy and I cannot get the image of Nurse Ratched delivering shock therapy out of my head…

Deep brain stimulation tested for Alzheimer's

© www.mentalhealthblog.com

Popular Posts

Dentalget.com is dental equipment supplier, we provide high quality dental instruments, dental handpiece at a discount price. Free shipping worldwide.

Categories

9/11 AADD Abortion Academic Success Acetylcholine ADD Adderall Addiction ADHD Adult Attention Deficit Disorder Adultery Advertising Aggression Aging Agreeableness AIDS Air Pressure Alcohol Alcohol Abuse Alcohol Dependence Alcoholism alpha-CaM kinase II Altitude Alzheimer's Amphetamine Amygdala Amyloid Amyloid Deposition Anesthesia Anger Anterior Cingulate Cortex Anterograde Amnesia Anti-Depressants Anti-Psychotic Anticholinergic Anticonvulsant Antiepileptic Antioxidants Anxiety Anxious-Avoidant Anxious-Preoccupied Apolipoprotein E Army Aromatherapy Asperger Syndrome Assessment Associative Learning Asthma Attachment Theory Attention Attention Deficit Disorder Attention Deficit Hyperactivity Disorder Autism Autism Spectrum Disorder Autonomic Nervous System Average Sleep Requirements B-type Natriuretic Peptide Babies Balance Behavioral Problems Behaviour Behavioural Impairment Behavioural Therapy Benadryl Bipolar Disorder Blood Clot Blood Pressure Blue Light Blue Light Goggles Body Mass Index Bone Marrow Brain Brain Development Brain Imaging Brain Injury Brain Stem Brain Surgery Breast Cancer Buddhism bullying Bupropion Business C-reactive Protein Calories CAMH Canada Canadian Charter of Rights and Freedoms Cancer Carbohydrates Cardiovascular Disease Care Facilities Caregiver cars Cdk5 Cell Phone Central Nervous System Centre for Addiction and Mental Health Cerebellum Cerebral Amyloid Angiopathy Cerebral Cortex Cerebrospinal Fluid Cerebrovascular Accident Cerebrovascular Insult Chat Rooms Chewing Childhood Disabilities Childhood Disintegrative Disorder Childhood Emotional Neglect Children Chitin Chitosan Cholesterol Choline Chromosome Chronic Pain Syndrome Chronic Stress Circadian Rhythm Cirrhosis Citalopram Classical Conditioning Climate Change Clot-Busting Drug Co-morbidity Cocaine Cognition Cognitive Development Cognitive Impairment Colloquially Brain Attack Coma Communication Device Communication Technology Concentration Concerta Concussion Conflict Confusion Conscientiousness Control Group Coordination Correlation Cortisol Counselling Couples CPAP Crack CRASH-2 CRASH-3 Creativity Criminal Code Cyberbullying Cyberpsychology Cyklokapron Daytrana Death Death Toll Decision-Making Declarative Memory Deep Brain Stimulation Delusion Dementia Dentures Depression Destrostat Deviant Behaviour Dexedrine Dextromethorphan Diabetes Diet Dietary Supplements Diphenhydramine Disability discrimination Dismissive-Avoidant Disorganized Attachment Disorganized Speech Disorientation Dizziness Docosahexaenoic Acid (DHA) Double-Blind Dream Drinking Drowsiness Drug Abuse Drug Dependence Drug Use Drugs DSM DSM-5 Dual Diagnosis Early Onset Alzheimer's Economic Crisis Ecstasy Effexor Ego Eicosapentaenoic Acid (EPA) Elderly Electrical Stimulation Electroconvulsive Therapy Electrodes Email Embitterment Embolic Emotion Emotional Neglect Emotional Problems Emotional Well-Being Employee Enrivonment Enzyme Epilepsy Estrogen Ethics Evolution Experimental Group Extracellular Signal-Regulated Kinase (ERK) Extroversion Facebook Facebook Fan Page Facebook Friends Family Family Therapy Fast Food Father Father Absenteeism Fatherhood FDA Fear Fearful-Avoidant FeelingBetterNow Fetus Fibrin Fish Oil fluoxetine fMRI Focalin Focus Food Fraud Friday Gamma Secretase Genetic Disorders Genetics Ginkgo Biloba Glucose Glutamate Receptor God Gout Guest Blogger Hair Pulling Haiti Hallucination Hallucinogenic Halo Effect Harm-Reduction Headache Healthy Eating Hearing Heart Attack Heart Disease Hematopoietic Stem Cells Hepatitis Hepatitis C Herbal Supplements Hereditary Angioedema Heredity Heroin High Blood Pressure Hippocampus Hockey Homelessness Hormone Housing Hox Genes Hoxb8 Cells Human Rights Hydromorphone Hyper-social Networker Hyperactivity Hypothalamus Illness Impulse Control Impulsivity Inattentiveness Infant Infidelity Inflammation Insecure Attachment Insomnia Instant Messaging Insulin Intellectual Development Intellectual Disability Internet Intracranial Bleeding Introversion Introvert Ischemic Stroke KASPAR Ketamine Ketogenic Kleptomania Laptop Latent Inhibition Learning Learning Disability Leukotrienes Limbic System Lithium Liver Locked-In Syndrome Long Term Memory Long-Term Potentiation Longevity Lupus Lysteda Maestro Rechargeable System Major Depression Mania MAOI Marriage MDMA Medication Meditation Melatonin Memory Memory Loss Memory Task Men Mental Health Mental Health Forum Mental Heath Mental Illness Metadate Metyrapone Mice Microglia Mild Cognitive Impairment (MCI) Mild Traumatic Brain Injury Military Mind-Body Mindless Eating Mitochondria MOHLTC Mood Disorder Morphine Mortality Rates MRI MS-275 Multiple Sclerosis Muscle Weakness music therapy Narcissism Natasha Richardson National Sleep Foundation Natural Disaster Nature/Nurture Nausea Necrosis Neglect Nerve Neuro-imaging Neurobiology Neurodegeneration Neurodegenrative Diseases Neurodevelopment Disorders Neurogenesis Neurological Disease Neuromarketing Neuron Neuropathy Neuroticism Neurotransmitter News Nintendo Wii Non-REM Sleep Nose Nurse Ratched Nutrition Obesity Obessive Compulsive Spectrum Disorder (OCD) Offspring Olfactory Gland OM3 Emotional Balance Omega 3 Ontario Ontario Review Board Ontario Works Opioid Oral Health Organic Ottawa Over-activity Over-Medication Ovulation Oxidative Cell Oxygen Oxytocin p35 Pacemaker Pain Pain Killer Pain Management Pancreatic Polypeptide Pancreatitis Paralysis Paranoia Paraskevidekatriaphobia Parenthood Parents Parkinson's Paroxetine Paxil PDD-NOS perception Perfume Peripheral Nervous System Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Pathway personality traits Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) PET Scan Pharmacology Phobias Physical Health Physiological Plasmin Plasminogen Plasticity Platelet-Activating Factor Politics Post-Concussion Assessment and Cognitive Test (ImPACT) Potassium Ion Channel Poverty Pregnancy Pressure Procedural Memory Promiscuity Prozac PsychBoard.com Psychiatric Ward Psychological Psychological Inventories Psychologist Psychology Psychology Forum Psychology of Eating Psychosis PTED PTSD Public Health Pyromania Quadriplegic Rehab Relationships Reliability Religion REM Research Retigabine Retrograde Amnesia Rett Syndrome Risperdal Ritalin road rage Robot Robotics Rodent Research Rosiglitazone Samsung Satiety Scales Schizophrenia School Screening Secure Attachment Sedatives Seizure Self-Affirmation Intervention Self-Confidence Self-Esteem Self-Integrity Self-Worth Semantic Memory Senior Seroquel Serotonin Serzone Sex Sex Therapy Sexual Orientation Sexual Satisfaction Shock Therapy Sideline Concussion Assessment Test (SCAT2) Sleep Sleep Apnea Sleep Disorders Sleep Quality Sleep Stages Smartphone Smoking Snacking Sniffing Technology Social Assistance Social Deficits Social Isolation Social Media Social Network Social Rejection Social Skills Social Worker Socialization Societal Change Soft Palate Soldier Somatic Nervous System Spatial Memory Special K Speech Spinal Cord Spinal Cord Injury Spinal Tap Sports Injury SSRI Statin Stem Cell Stimulant Strattera Stress Stress Hormone Stroke Substance Abuse Sugar Suicide Superstition Support Survey Suspicious Tablet Talk Therapy Tamoxifen Tanorexia Tax Payer Technology Television Telomere Temperature Testosterone Texting Therapy Thorazine Threshold Thrombosis Thrombotic Tinnitus Tissue Plasminogen Activator Topographical Disorientation Tranexamic Acid Trauma Treatment Tremors Trial Tribunal Trichotillomania Type-2 Diabetes Vagus Nerve Validity Ventromedial Prefrontal Cortex Video Games Virtual Reality Vision Visual Attention Vitamin B Vitamins Vitiligo Voice Vyvanse Walnuts Weight Loss Welfare Wellbutrin Wernicke–Korsakoff syndrome Wet Brain White Blood Cells Women Work World Health Organization Zileuton Zyban Zyprexa µ-opiate receptors (MOR)